Skip to main content

Advertisement

Table 4 Health-related quality of life (HRQOL) scores according to physical activity levels among breast cancer survivors with stage II and III breast cancer

From: The association between physical activity and health-related quality of life among breast cancer survivors

HRQOL Items Physical Activity (MET-hours per week)
All Tertile 1 Tertile 2 Tertile 3 P for trenda
EORTC QLQ-C30, LS means (95% CI)b
Global health status / QoL 113 48.33 (32.27, 72.39) 31.37 (19.83, 49.61) 43.56 (28.54, 66.49) 0.89
Functioning
 Physical Functioning 128 81.46 (68.05, 97.51) 85.19 (69.31, 104.72) 81.99 (67.23, 99.98) 0.98
 Role Functioning 129 76.34 (53.02, 109.91) 100.65 (65.83, 153.89) 95.71 (64.41, 142.23) 0.36
 Emotional Functioning 130 72.94 (59.76, 89.03) 67.19 (53.42, 84.51) 75.44 (60.73, 93.71) 0.63
 Cognitive Functioning 130 77.05 (59.64, 99.56) 69.47 (51.73, 93.29) 75.00 (56.74, 99.13) 0.96
 Social Functioning 130 59.44 (42.46, 83.22) 78.02 (52.98, 114.91) 70.92 (49.17, 102.29) 0.49
Symptom
 Fatigue 129 18.19 (12.29, 26.91) 19.25 (12.25, 30.25) 11.47 (7.43, 17.71) 0.02
 Nausea / Vomiting 130 2.53 (1.38, 4.63) 2.20 (1.09, 4.41) 2.17 (1.12, 4.19) 0.69
 Pain 129 11.40 (5.74, 22.67) 7.32 (3.32, 16.17) 6.15 (2.87, 13.17) 0.14
 Dyspnea 129 5.29 (2.60, 10.74) 2.90 (1.28, 6.57) 3.93 (1.79, 8.61) 0.63
 Insomnia 128 12.16 (6.05, 24.45) 19.57 (8.75, 43.75) 12.05 (5.56, 26.12) 0.78
 Appetite loss 128 2.28 (1.25, 4.15) 3.06 (1.53, 6.09) 2.11 (1.09, 4.10) 0.67
 Constipation 128 3.90 (1.87, 8.15) 3.56 (1.53, 8.27) 1.93 (0.86, 4.34) 0.08
 Diarrhea 130 2.72 (1.36, 5.45) 2.11 (0.95, 4.69) 3.51 (1.65, 7.46) 0.40
 Financial Problems 130 5.33 (2.56, 11.10) 8.65 (3.72, 20.11) 4.30 (1.94, 9.56) 0.42
EORTC QLQ-BR23, LS means (95% CI)b
Functioning
 Body image 130 26.17 (14.74, 46.48) 24.74 (12.78, 47.91) 22.67 (12.13, 42.35) 0.66
 Sexual functioning 115 1.97 (1.00, 3.85) 1.61 (0.76, 3.41) 5.77 (2.92, 11.39) 0.001
 Sexual enjoyment 36 10.24 (1.60, 65.60) 3.36 (0.64, 17.61) 7.46 (1.29, 43.12) 0.97
 Future perspective 130 16.23 (8.49, 31.02) 12.63 (5.99, 26.62) 15.43 (7.62, 31.23) >0.99
Symptom
 Systematic therapy side effects 130 23.04 (16.92, 31.36) 30.31 (21.25, 43.22) 23.11 (16.52, 32.33) 0.75
 Breast symptoms 130 16.84 (9.26, 30.60) 11.09 (5.58, 22.06) 14.16 (7.39, 27.13) 0.77
 Arm symptoms 130 19.83 (11.69, 33.65) 26.64 (14.50, 48.95) 22.71 (12.77, 40.37) 0.78
 Upset by hair loss 88 19.92 (7.97, 49.81) 26.82 (9.60, 74.98) 22.28 (8.72, 56.92) 0.89
  1. MET metabolic equivalent, EORTC QLQ-C30 European organization for research and treatment of cancer quality of life questionnaire core 30, LS least-squares, CI confidence interval, EORTC QLQ-BR23 European organization for research and treatment of cancer quality of life questionnaire breast cancer module 23
  2. aP for trend was calculated using the median value of each tertile category as a continuous variable
  3. bAdjusted for age (year: continuous), energy intake (kcal/day: continuous), dietary supplement use (yes, no), education level (high school or less, college or more), marital status (married or cohabitated, unmarried or divorced or widowed), time since surgery (6 month – 1 year, 1 year - 5 years, ≥ 5 years), stage (II or III), and center